(Q28304901)
Statements
Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adults (English)
0 references
19 June 2007
0 references
21
0 references
1293-9
0 references
10
0 references